Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Ito

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Clinical Pharmacology|July 17, 2001
The effects of converting from simvastatin to atorvastatin on plasminogen activator inhibitor type-1M K Ito
Journal of Clinical Pharmacology|May 20, 1998
Effects of extensive and poor gastrointestinal metabolism on the pharmacodynamics of pravastatinM K Ito
The American Journal of Cardiology|October 7, 1997
Pravastatin alone and in combination with low-dose cholestyramine in patients with primary hypercholesterolemia and coronary artery diseaseM K Ito, R Shabetai
Pharmacotherapy|July 11, 2001
Fenofibrate and warfarin interactionM A Aldridge, M K Ito
The American Journal of Medicine|July 18, 1991
Skin pretreatment and the use of transdermal clonidineM K Ito, D T O'Connor
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|September 1, 1996
The biosynthesis of omega 3 fatty acids from 18:2 omega 6 in Artemia sppM K Ito, K L Simpson
The Annals of Pharmacotherapy|March 20, 1999
Chronic creatine kinase elevation not associated with HMG-CoA reductase inhibitor treatmentJ C Lin, M K Ito
The Annals of Pharmacotherapy|August 4, 2001
Colesevelam hydrochloride: a novel bile acid-binding resinM A Aldridge, M K Ito
Clinical Pharmacy|July 1, 1992
Ticlopidine: a new platelet aggregation inhibitorM K Ito, A R Smith, M L Lee
Journal of Cardiovascular Pharmacology and Therapeutics|August 18, 2001
The relationship between low-density lipoprotein cholesterol goal attainment and prevention of coronary heart disease--related eventsM K Ito, G M Delucca, M A Aldridge
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Clinical Pharmacology|July 17, 2001
The effects of converting from simvastatin to atorvastatin on plasminogen activator inhibitor type-1M K Ito
Journal of Clinical Pharmacology|May 20, 1998
Effects of extensive and poor gastrointestinal metabolism on the pharmacodynamics of pravastatinM K Ito
The American Journal of Cardiology|October 7, 1997
Pravastatin alone and in combination with low-dose cholestyramine in patients with primary hypercholesterolemia and coronary artery diseaseM K Ito, R Shabetai
Pharmacotherapy|July 11, 2001
Fenofibrate and warfarin interactionM A Aldridge, M K Ito
The American Journal of Medicine|July 18, 1991
Skin pretreatment and the use of transdermal clonidineM K Ito, D T O'Connor
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|September 1, 1996
The biosynthesis of omega 3 fatty acids from 18:2 omega 6 in Artemia sppM K Ito, K L Simpson
The Annals of Pharmacotherapy|March 20, 1999
Chronic creatine kinase elevation not associated with HMG-CoA reductase inhibitor treatmentJ C Lin, M K Ito
The Annals of Pharmacotherapy|August 4, 2001
Colesevelam hydrochloride: a novel bile acid-binding resinM A Aldridge, M K Ito
Clinical Pharmacy|July 1, 1992
Ticlopidine: a new platelet aggregation inhibitorM K Ito, A R Smith, M L Lee
Journal of Cardiovascular Pharmacology and Therapeutics|August 18, 2001
The relationship between low-density lipoprotein cholesterol goal attainment and prevention of coronary heart disease--related eventsM K Ito, G M Delucca, M A Aldridge
Pageof 2